Skip to main content
    AngelBacked

    Xilio Therapeutics

    BiopharmaWaltham, Massachusetts, United StatesPost-IPO Equity$370.1M total fundingwww.xiliotx.com
    Latest funding:$40.0M · Post-IPO Equity (February 11, 2026)

    Angel investors who backed Xilio Therapeutics

    46 investors in our database backed Xilio Therapeutics.

    Kevin Bitterman

    Partner

    Eugene Hill

    Managing Partner

    Michael Balmuth

    Managing Partner

    Houman Ashrafian

    Executive Vice President, Head of Research and Development

    Gregory Madden

    Managing Partner

    Paul LaViolette

    Managing Partner & Chief Operating Officer

    Bruce Booth

    Partner

    Jason Rhodes

    Partner

    Jernej Godec

    Principal

    Brent Faduski

    Chief Financial Officer and Partner

    Kate Bingham

    Managing Partner

    Tom Flynn

    Managing Partner

    Elizabeth Blake Schwert

    Senior Associate

    Alex Harding

    Senior Associate

    Jean-FranÔøΩEois Formela

    Partner

    Carl Culicchia

    Principal

    Chelsea Place Johnson

    Senior Associate

    Ommer Chohan

    CFO

    Mike Ross

    Managing Partner

    Steven Robinette

    Principal

    Lionel Carnot

    Board Member

    carl goldfischer

    Medical Doctor

    Fred Craves

    Owner

    Matt Kronmiller

    Vice President

    David Beier

    Managing Director

    Dayton Misfeldt

    Managing Director

    Manuel LÔøΩEpez-Figueroa

    Managing Director

    Julian Schubert

    Senior Controller - Financial Planning & Analysis Life Science

    Hakan Goker

    Managing Director

    Owen Lozman

    Managing Director

    Christian Patze

    Investment Director, Technology Investments

    Noga Yerushalmi

    Investment director at M Ventures - Head of Israel Bio-incubator

    Sebastian Schoefer

    Investment Director, Technology Investments

    Javier Rodriguez

    CFO at M Ventures

    Karen Spilizewski

    Managing Director

    Derek Rapp

    Managing Director

    Niall O`Donnell

    Managing Director

    Michael Berman

    General Dentist

    Jay Schmelter

    Co-Founder and Managing Director

    John McKearn

    Managing Director

    Sivan Weitzman

    CFO

    Curtis Rother

    Senior Analyst

    Tom Melzer

    Co-founder, Managing Director

    Michael Gladstone

    Partner

    Atlas Venture

    David Grayzel

    Partner

    Atlas Venture

    Peter Dudek

    Board Observer

    View the full investor list for Xilio Therapeutics

    Find the right investors for your startup

    Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Xilio Therapeutics.

    Search investors